Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C

Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C

Background and rationale. The REPLACE study (NCT01571583) investigated telaprevir-based triple therapy in patients who have recurrent genotype 1 hepatitis C virus (HCV) infection following liver transplantation and are on a stable immunosuppressant regimen of tacrolimus or cyclosporin A. Patients re...

Celý popis

Podrobná bibliografie
Hlavní autoři: Xavier Forns, Didier Samuel, David Mutimer, Stefano Fagiuoli, Miquel Navasa, Kosh Agarwal, Marina Berenguer, Massimo Colombo, Kerstin Herzer, Frederik Nevens, Bjorn Daems, Katrien Janssen, Sivi Ouwerkerk-Mahadevan, Holly Kimko, Erkki Lathouwers, James Witek, Rodica Van Solingen-Ristea
Médium: Článek
Jazyk:English
Vydáno: Elsevier 2016-07-01
Edice:Annals of Hepatology
Témata:
Telaprevir
Hepatitis C infection
Liver transplant
On-line přístup:http://www.sciencedirect.com/science/article/pii/S1665268119311391

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119311391

Podobné jednotky